Libor Zamecnik
Research Subjects
Research Interests
Libor Zamecnik has a total of 79 co-authors. Here are the top co-authors by number of shared publications:
T. Hanus
6 shared publications- Tomas Hanus
Department of Urology, General University Hospital and 1st Faculty of Medicine, Charles University, Prague, Czech Republic
6 shared publications - Michael Pešl
LF UK Univerzita Karlova Praha § Ústav patologie VFN
5 shared publications - Petr Macek
Urology Department, Institut Mutualiste Montsouris, Paris
5 shared publications Z. Valova
5 shared publications- Viktor Soukup
Department of Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
4 shared publications
Latest Publications
- 1 November 2017
- Published by Elsevier in European Urology Supplements
- Vol. 16 (11) , e2852
Surgical treatment of vesicovaginal fistulas
- 1 November 2017
- Published by Elsevier in European Urology Supplements
- Vol. 16 (11) , e2852
Surgical treatment of vesicovaginal fistulas
- 31 March 2017
- Published by Care Comm in Česká a slovenská neurologie a neurochirurgie
- Vol. 80/113 (2) , 233-236
Guidelines for Diagnosis and Treatment of Lower Urinary Tract Symptoms in Patients with Multiple Sclerosis in the Czech Republic – Interdisciplinary Expert Consensus Using DELPHI Methodology
- 31 March 2017
- Published by Care Comm in Česká a slovenská neurologie a neurochirurgie
- Vol. 80/113 (2) , 233-236
Guidelines for Diagnosis and Treatment of Lower Urinary Tract Symptoms in Patients with Multiple Sclerosis in the Czech Republic – Interdisciplinary Expert Consensus Using DELPHI Methodology
- Open Access
- 29 January 2014
- Published by S. Karger AG in Urologia Internationalis
- Vol. 92 (2) , 150-156
The Prognostic Value of T1 Bladder Cancer Substaging: A Single Institution Retrospective Study
Objective: To evaluate the prognostic value of the depth of lamina propria invasion in patients with T1 bladder cancer. Subjects and Methods: 200 patients were treated between the years 2002 and 2009. Tumours with depth of invasion above the muscularis mucosae level were categorised as pT1a and those with depth of invasion up to or beyond the muscularis mucosae as pT1b. Results: Categorisation for pT1a and pT1b was performed in 176 of 200 patients (88%). In 10 patients a muscle-invasive tumour was found in re-transurethral resection samples. 131 (79%) of 166 analysed patients had pT1a tumour and 35 (21%) had pT1b tumour. During the follow-up, in 101 (61%) patients the tumour had recurred and in 27 (16.3%) the tumour had progressed. Of all the investigated parameters, T1 substaging (p < 0.0001), grade (p = 0.0003) and the number of bacillus Calmette-Guérin instillations (p = 0.0490) were significant in predicting progression. The only significant factor for disease-specific survival was T1 substaging in univariable (p = 0.0008) and multivariable (hazard ratio 4.407) analysis. T1 substaging (p = 0.0149) and tumour multiplicity (p = 0.0448) have a statistically significant prognostic value with respect to overall survival. Conclusions: Deep invasion of the lamina propria is a significant adverse prognostic factor for tumour progression, disease-specific survival and overall survival.
- 29 January 2014
- Published by S. Karger AG in Urologia Internationalis
- Vol. 92 (2) , 150-156
Open AccessThe Prognostic Value of T1 Bladder Cancer Substaging: A Single Institution Retrospective Study
Objective: To evaluate the prognostic value of the depth of lamina propria invasion in patients with T1 bladder cancer. Subjects and Methods: 200 patients were treated between the years 2002 and 2009. Tumours with depth of invasion above the muscularis mucosae level were categorised as pT1a and those with depth of invasion up to or beyond the muscularis mucosae as pT1b. Results: Categorisation for pT1a and pT1b was performed in 176 of 200 patients (88%). In 10 patients a muscle-invasive tumour was found in re-transurethral resection samples. 131 (79%) of 166 analysed patients had pT1a tumour and 35 (21%) had pT1b tumour. During the follow-up, in 101 (61%) patients the tumour had recurred and in 27 (16.3%) the tumour had progressed. Of all the investigated parameters, T1 substaging (p < 0.0001), grade (p = 0.0003) and the number of bacillus Calmette-Guérin instillations (p = 0.0490) were significant in predicting progression. The only significant factor for disease-specific survival was T1 substaging in univariable (p = 0.0008) and multivariable (hazard ratio 4.407) analysis. T1 substaging (p = 0.0149) and tumour multiplicity (p = 0.0448) have a statistically significant prognostic value with respect to overall survival. Conclusions: Deep invasion of the lamina propria is a significant adverse prognostic factor for tumour progression, disease-specific survival and overall survival.
- Open Access
- 1 January 2014
- Published by Charles University in Prague, Karolinum Press in Folia Biologica
- Vol. 60 (6) , 286-289
Podoplanin (D2-40) is a Reliable Marker of Urinary Bladder Myofibroblasts (Telocytes)
Podoplanin, D2-40, has been described in a variety of normal and neoplastic tissues. It is often used for highlighting lymphatics. We evaluated the expression of podoplanin in α-smooth muscle actinpositive myofibroblasts producing the suburothelial layer in tunica propria of the urinary bladder that have some similar features with telocytes. Our results showed that these cells demonstrate distinct D2-40 immunoreactivity from telocytes occurring in the renal pelvis and ureter. We observed positive reaction not only in bioptic specimens from women with interstitial cystitis, but also in a control group of women and men treated for pathological bladder lesion different from interstitial cystitis. It is interesting that identical staining reaction was observed in the ureters only exceptionally. In addition, we examined samples from myofibroblastic tumoriform lesions of soft tissue such as nodular fascitis and fibromatosis (desmoid) and we obtained negative results. It means that the so-called myofibroblasts of urinary bladder tunica propria have a unique immunophenotype that has probably not been described until now. Our findings suggest that D2-40 can be used as a complementary immunostainer to α-smooth muscle actin on urinary bladder biopsies from patients with interstitial cystitis. The role of D2-40 as an immunohistochemical marker is still being investigated.
- 1 January 2014
- Published by Charles University in Prague, Karolinum Press in Folia Biologica
- Vol. 60 (6) , 286-289
Open AccessPodoplanin (D2-40) is a Reliable Marker of Urinary Bladder Myofibroblasts (Telocytes)
Podoplanin, D2-40, has been described in a variety of normal and neoplastic tissues. It is often used for highlighting lymphatics. We evaluated the expression of podoplanin in α-smooth muscle actinpositive myofibroblasts producing the suburothelial layer in tunica propria of the urinary bladder that have some similar features with telocytes. Our results showed that these cells demonstrate distinct D2-40 immunoreactivity from telocytes occurring in the renal pelvis and ureter. We observed positive reaction not only in bioptic specimens from women with interstitial cystitis, but also in a control group of women and men treated for pathological bladder lesion different from interstitial cystitis. It is interesting that identical staining reaction was observed in the ureters only exceptionally. In addition, we examined samples from myofibroblastic tumoriform lesions of soft tissue such as nodular fascitis and fibromatosis (desmoid) and we obtained negative results. It means that the so-called myofibroblasts of urinary bladder tunica propria have a unique immunophenotype that has probably not been described until now. Our findings suggest that D2-40 can be used as a complementary immunostainer to α-smooth muscle actin on urinary bladder biopsies from patients with interstitial cystitis. The role of D2-40 as an immunohistochemical marker is still being investigated.
- 1 October 2013
- Published by Elsevier in European Urology Supplements
- Vol. 12 (4)
C100 Endoscopic extraperitoneal radical prostatectomy and its complications – analysis of the first 300 procedures
- 1 October 2013
- Published by Elsevier in European Urology Supplements
- Vol. 12 (4)
C100 Endoscopic extraperitoneal radical prostatectomy and its complications – analysis of the first 300 procedures
- 1 October 2013
- Published by Elsevier in European Urology Supplements
- Vol. 12 (4) , e1153, C45
C45 Detection of venous leakage using CT Cavernography in men with Erectile Dysfunction
- 1 October 2013
- Published by Elsevier in European Urology Supplements
- Vol. 12 (4) , e1153, C45
C45 Detection of venous leakage using CT Cavernography in men with Erectile Dysfunction
- 1 October 2013
- Published by Elsevier in European Urology Supplements
- Vol. 12 (4) , e1162, C54
C54 Intraurethral insertion of foreign bodies
- 1 October 2013
- Published by Elsevier in European Urology Supplements
- Vol. 12 (4) , e1162, C54
C54 Intraurethral insertion of foreign bodies
- 1 October 2012
- Published by Elsevier in European Urology Supplements
- Vol. 11 (4) , 108
C109 SHOCK WAVE THERAPY IN PATIENTS WITH PEYRONIE'S DISEASE – OUR EXPERIENCE
- 1 October 2012
- Published by Elsevier in European Urology Supplements
- Vol. 11 (4) , 108
C109 SHOCK WAVE THERAPY IN PATIENTS WITH PEYRONIE'S DISEASE – OUR EXPERIENCE
- 1 October 2012
- Published by Elsevier in European Urology Supplements
- Vol. 11 (4) , 96
C60 ENDOSCOPIC EXTRAPERITONEAL RADICAL PROSTATECTOMY – ANALYSIS OF THE FIRST 217 PROCEDURES
- 1 October 2012
- Published by Elsevier in European Urology Supplements
- Vol. 11 (4) , 96
C60 ENDOSCOPIC EXTRAPERITONEAL RADICAL PROSTATECTOMY – ANALYSIS OF THE FIRST 217 PROCEDURES